The Effect of Low-Dose Proteasome Inhibition on Pre-Existing Atherosclerosis in LDL Receptor-Deficient Mice
Dysfunction of the ubiquitin-proteasome system (UPS) has been implicated in atherosclerosis development. However, the nature of UPS dysfunction has been proposed to be specific to certain stages of atherosclerosis development, which has implications for proteasome inhibition as a potential treatment...
Main Authors: | Nicola Wilck, Mandy Fechner, Cristian Dan, Verena Stangl, Karl Stangl, Antje Ludwig |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/4/781 |
Similar Items
-
Coxsackievirus B3 Exploits the Ubiquitin-Proteasome System to Facilitate Viral Replication
by: Martin Voss, et al.
Published: (2021-07-01) -
Regulation of Proteasome Activity by (Post-)transcriptional Mechanisms
by: Suzan Kors, et al.
Published: (2019-07-01) -
Potential role of proteasome on c-jun related signaling in hypercholesterolemia induced atherosclerosis
by: Erdi Sozen, et al.
Published: (2014-01-01) -
The Role of Autophagy in Chemical Proteasome Inhibition Model of Retinal Degeneration
by: Merry Gunawan, et al.
Published: (2021-07-01) -
The proteasome and the degradation of oxidized proteins: Part I—structure of proteasomes
by: Tobias Jung, et al.
Published: (2013-01-01)